Samsung Biologics

Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal

South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8...